This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ThousandOaks-based Amgen said Wednesday afternoon that it is cutting 380 jobs from the firm, as part of a corporate restructuring. The firm said it is cutting 226 people in its ThousandOaks headquarters. READ MORE>>.
HARDATA , a developer of workflow management software for the broadcast and entertainment industry, has set up shop in ThousandOaks, and hired a new President and CEO. The Argentina-based software developer said it has named Philip B. Cox as President and CEO, and opened up its world headquarters in the United States.
ThousandOaks-based Atara Biotherapeutics , which is developing treatments for patients with cancer, autoimmune and infectious disease, has leased a 90,000 square foot building in the Conejo Spectrum, according to developer SARES-REGIS Group.
ThousandOaks-based biotech company Capsida Biotherapeutics says it has opened up a new, 15,000 square-foot facility in ThousandOaks for its gene therapy manufacturing efforts. The company says that building its own manufacturing facility will help it eliminate dependence on ontract manufacturing.
ThousandOaks-based Amgen , and Monrovia-based Xencor said Thursday that the two firms are in a co-development dual around a new novel antibody for treating autoimmune diseases. The firms said that XmAb5871 is currently in late-stage preclinical development for the treatment of autoimmune diseases. READ MORE>>.
ThousandOaks- and Shanghai-based ThousandOaks Biopharmaceuticals , a new contract manufacturing organization fort he biotech industry, said it has received $45M in a Series A financing round. The company's Chairman is Shun Luo, Ph.D.,
ThousandOaks-based Ceres , the developer of seeds for the energy and biofuels industry, said today that its Brazilian subsidiary, Ceres Sementes do Brasil Ltda., is in a deal with Syngenta to develop sweet sorghum-based products to power Brazil's ethanol mills.
ThousandOaks-based Amgen reported this morning that it has completed its tender offer for Onyx Pharmaceuticals , and now expects its acquisition to complete today. Amgen is paying $125 per share in cash for publicly held Onyx Pharmaceuticals, a developer of biopharmaceuticals for treating cancer.
ThousandOaks-based Teledyne Technologies said last week that it has acquired Photon Machines , a developer of laser-based, laboratory instrumentation. Its corporate headquarters and research labs are in ThousandOaks. Financial terms of the buy were not disclosed. Photon Machines was based in Bozeman, Montana.
ThousandOaks-based wireless hardware provider Xirrus has raised yet another $10M in funding, according to a regulatory filing from the company Monday. Xirrus develops specialized, Wi-Fi hotspots specifically aimed at high density and high performance installations, such as campuses and public areas.
Online real estate site Move said this morning it has acquired SocialBios , a developer of an online business referral and social search startup. Move is based in Campbell, California, with operations in ThousandOaks. Financial terms of the acquisition were not disclosed. Socialbios is based in Denver. READ MORE>>.
ThousandOaks-based Servoy , a developer of software for developing software-as-a-service applications, said Monday that it has upgraded its namesake platform. Tags: development saas software servoy.
ThousandOaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex , a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. BioVex develops OncoVEX, a novel oncolytic vaccine in Phase 3 clinical development. READ MORE>>.
ThousandOaks-based Xirrus , the developer of wireless networking equipment, said today that it has named Steven Wastie as its Chief Marketing Officer. Wastie has previously served in similar roles at iPass, Juniper Networks, Inktomi, Netscaape, and At&T Online Services. READ MORE>>.
ThousandOaks-based Amgen and venture firm Kleiner Perkins Caufield & Byers have put their backing behind a new, Westlake Village based drug development firm, Atara Biotherapeutics , in an unusual spinout of technology from the biotech giant. Financial details of the funding were not announced.
ThousandOaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease.
ThousandOaks-based Xirrus , the developer of high performance wireless access points, reported today that it has deployed its products in Gillette Stadium, the home of the New England Patriots. According to Xirrus, its wireless network will serve premium seating areas, as part of the Gillette Stadium Putnam Club.
ThousandOaks-based Ceres , a developer of energy crops for the biofuels energy, has landed $4,989,144 in a grant from the Department of Energy, as part of a $151M effort to fund energy breakthroughs. The effort is targeted at creating feed stocks for biofuels projects, to displace oil and coal.
ThousandOaks-based Xirrus , a developer of Wi-Fi arrays, said today that it has deployed its products at the Illawara Grammar School located on the South Coast of New South Wales, Australia. Financial impact of the sale was not disclosed.
ThousandOaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. Theraclone is developing therapeutic antibodies for treating infectious disease and cancer.
ThousandOaks-based biotech giant Amgen said this morning that it has agreed to buy KAI Pharmaceuticals , a developer of treatments for secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) who are on dialysis, for $315M in cash. KAI Pharmaceuticals is based in South San Francisco.
ThousandOaks-based Xirrus , a developer of Wi-Fi arrays, announced today that it has deployed its products at a school in Atlanta, Georgia. Xirrus said it has deployed its products at the Paideia School, a 16-acre school serving 900 students from age three through 12th grade. Financial impact of the win was not disclosed.
ThousandOaks-based Teledyne Technologies announced early this morning that it has acquired English machine vision and image sensor technology developer e2v technologies plc. The deal is worth approximately $789M. Teledyne said that e2v had asles of 236 million pounds for the year ended March 31, 2016.
Xirrus , the wireless hardware provider based in ThousandOaks, has just raised $10.1M Xirrus develops wireless hotspot equipment which is particularly useful for high density and high performance networks, including both corporate networks, large campuses, conference centers, schools, and other locations.
Amgen Ventures , the venture capital arm of ThousandOaks-based Amgen , has re-upped on an investment in a biopharmaceuticals developing microRNA-based treatments for cardiovascular and muscle disease. and Broadview Ventures. miRagen is based in Boulder, Colorado.
ThousandOaks-based Teledyne Technologies , the diversified electronics, instrumentation, aerospace and defense firm, reported Thursday that its subsidiary, Teledyne Brown Engineering, has won a $350M NASA Engineering contract. READ MORE>>.
ThousandOaks-based biotech giant Amgen announced Sunday that it has acquired San Francisco biopharmaceuticals company Onyx Pharmaceuticals , in a deal worth $10.4 Onyx is a developer of biopharmaceuticals used to help patients with cancer. Amgen said it will pay $125 per share inc ash for Onyx Pharmaceuticals. READ MORE>>.
ThousandOaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. According to the company, the funding came from Ally Bridge Group.
ThousandOaks-based Teledyne Technologies said this morning that it has acquired a minority stake in Optech , a developer of three dimensional, lidar-based imaging systems. Financial details of the acquisition were not disclosed. Teledyne said the investment was made through its subsidiary, Teledyne DALSA.
ThousandOaks-based agricultural biotech developer Ceres said this morning that its product development programs in Brazil are now being funded in part by that country. Ceres is developing seeds using biotechnology, aimed at energy production. READ MORE>>.
ThousandOaks-based Xirrus , the developer of Wi-Fi equipment, continues to rack up education wins, saying today that it has added the New College of Florida as a customer. Xirrus develops high capacity, switching Wi-Fi hotspots which are particularly well suited to the densities of colleges and universities.
ThousandOaks-based Teledyne Technologies announced this morning that it is acquiring Waterloo, Ontario-based DALSA Corporation , a developer of digital imaging and microelectromechanical systems (MEMS). Teledyne said it would pay approximately CAD $341M for DALSA in cash.
ThousandOaks-bsaed Teledyne Technologies said late Tuesady evening that it is acquiring Swindon, United Kingdom-based INtelek plc , a firm which designs and manufactures electronics systems for satellite and microwave communications. The deal is worth approximately $52.0M.
ThousandOaks-based Amgen announced today that it is acquiring Micromet , a biopharmaceuticals firm based in Germany and Rockville, Maryland, in a deal worth $1.16
ThousandOaks-based Xirrus , the developer of high speed, high performance wireless networking hardware, has raised another big chunk of financing, saying today that it has raised $23.5M in a Series E funding round. Xirrus said the funding will go towards sales growth and its product.
ThousandOaks-based Ceres , a developer of biofuel crop technology, has raised another $20M in funding, according to a regulatory filing from the firm Friday. Source of the new funding was not disclosed. The filing indicates the round came from five investors.
The highest ranking firm on the list in the area was PaymentMax , an electronic payments processor in ThousandOaks, with 10,058 percent growth over 3 years; among many, many other local companies were Prodege, the parent firm of Swagbucks , at number 43 (4461% growth); Santa Barbara-based FastSpring , at number 53 and 3,851% growth; and San Diego's (..)
ThousandOaks-based Teledyne Technologies said this morning that it has increased its stake in Optech Incorporated , from 19 percent to 51 percent of the company. Optech is an Ontario, Canada-based developer of laser-based survey and digital imaging instrumentation products, with 285 employees.
ThousandOaks-based Teledyne Technologies announced this morning that it has entered into an agreement to acquire RESON A/S , a developer of high-resolution marine acoustic imaging and measurement products. Financial terms of the buy were not disclosed.
ThousandOaks-based Teledyne Technologies Incorporate said Tuesday that one of its subsidiaries, Teledyne Energy Systems , has scored a $17.6M That technology was developed for the Mars Curiosity rover and its MMRTG (Multi Mission Radioisotope Thermoelectric Generator). contract from the NASA Jet Propulsion Laboratory (JPL).
Amgen Ventures , the venture capital arm of ThousandOaks-based Amgen , has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes.
ThousandOaks-based Teledyne Technologies has acquired laboratory automation and instrument developer CETAC Technologies , the company annoucned this morning. Financial details of the buy were not announced.
ThousandOaks-based Amgen and Colorado-based Array BioPharma announced Monday evening that Amgen is licensing the exclusive worldwide rights to Array's compounds for treating Type 2 diabetes, in a deal worth $60M plus additional contingent payments. Tags: amgen diabetes array biopharma lifescience biotech drug development.
ThousandOaks-based Servoy , a developer of software for creating web-based applications, said Friday that the firm has upgraded its products. Tags: servoy thousandoaks software saas. The firm said the latest update, version 4.1, includes over 350 enhancements and fixes. The firm said the latest update, version 4.1,
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content